Aileron Therapeutics, Inc. Soared
Fri, Mar 25, 2022 at 05:30 PM
Aileron Therapeutics, Inc. (ALRN:NASDAQ) shot up at $0.58, a gain of 25.5%. On Thu, Mar 24, 2022, ALRN:NASDAQ hit a New 2-Week High of $0.46. The stock appeared on our News Catalysts scanner on Tue, Mar 22, 2022 at 09:44 AM in the 'MISCELLANEOUS' category. From Thu, Mar 10, 2022, the stock recorded 60.00% Up Days and 63.64% Green Days
About Aileron Therapeutics, Inc. (ALRN:NASDAQ)
Aileron Therapeutics Inc is a clinical-stage biopharmaceutical company that is focused on developing and commercializing a novel class of therapeutics called stapled peptides.
Top 10 Gainers:
- Clever Leaves Holdings Inc. (CLVR:NASDAQ), 143.04%
- Forge Global Holdings Inc. (FRGE:NYSE), 50.2%
- Fresh Vine Wine Inc. (VINE:NYSEMKT), 33.65%
- NextDecade Corporation (NEXT:NASDAQ), 32.22%
- Clarus Therapeutics Holdings Inc. (CRXT:NASDAQ), 25.95%
- Aileron Therapeutics, Inc. (ALRN:NASDAQ), 25.54%
- NexImmune Inc. (NEXI:NASDAQ), 23.12%
- Tilray, Inc. (TLRY:NASDAQ), 22.81%
- Rockwell Medical, Inc. (RMTI:NASDAQ), 22.63%
- Kidpik Corp. (PIK:NASDAQ), 22.54%